


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+1.61%
+0.19%
+3.47%
+2.74%
IBRX
ImmunityBio
$5.95
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Investors confidence is positive
IBRX Price Performance
$6.48 (-8.18%)
$2.14 (+178.04%)
$2.59 (+129.73%)
$3.02 (+97.02%)
Overall standing based on market and analyst consensus.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Revenue increase YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
IBRX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IBRX Street Sentiment is extremely bullish and have positive views on the near-term outlook
IBRX has Low risk level
Risks Indicators

High volatilty

Average key support and resistance price levels
Recent Upgrades and Downgrades
STRONG BUY
Date
Action
Rating
Firm
Dec 17, 2025
Reiterate
Buy
D. Boral Capital
Dec 13, 2025
Reiterate
Buy
Jefferies
Dec 12, 2025
Reiterate
Buy
D. Boral Capital
Nov 14, 2025
Reiterate
Buy
D. Boral Capital
Nov 06, 2025
Reiterate
Buy
D. Boral Capital
CRSP
CRISPR Therapeutics
53.07
+8.46%
CLDI
Calidi Biotherapeutics In
0.78
+4.25%
What is IBRX current stock price?
What are IBRX stock strengths?
What is IBRX Risk Level?
What is IBRX market cap and volume?
What is IBRX current Stock IQ?
Should I buy IBRX stock right now?
Is IBRX a Strong Buy right now?
What does a 'Strong Buy' rating mean for IBRX?
What does a 'Strong Sell' rating mean for IBRX?
What factors influence IBRX's Stock IQ?
Join our subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+1.61%
+0.19%
+3.47%
+2.74%
IBRX
ImmunityBio
Current Price
$5.95
Runners Also Watch
CRSP
CRISPR Therapeutics
53.07
+8.46%
CLDI
Calidi Biotherapeutics In
0.78
+4.25%

IBRX Price Performance
$6.48 (-8.18%)
$2.14 (+178.04%)
$2.59 (+129.73%)
$3.02 (+97.02%)
IBRX Analysts Opinion
Overall standing per market and analyst expectations.
Hover over the category for more information
Earnings
Earnings

Reported a strong earnings

Revenue increase YoY

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity

Investors confidence is positive
Future
Future

Earnings are forecast to grow
![]()
IBRX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction and growth potential
IBRX Street Sentiment is extremely bullish and have positive views on the near-term outlook
IBRX has Low risk level
Risks Indicators

High volatilty

Average key support and resistance price levels
Overall Wall Street Rating
STRONG BUY
Dec 17, 2025
Reiterate
Buy
D. Boral Capital
Dec 13, 2025
Reiterate
Buy
Jefferies
Dec 12, 2025
Reiterate
Buy
D. Boral Capital
Nov 14, 2025
Reiterate
Buy
D. Boral Capital
Nov 06, 2025
Reiterate
Buy
D. Boral Capital
IBRX Stock IQ
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Investors confidence is positive
IBRX Latest Analysis
Is ImmunityBio Inc Gaining or Losing Market Support?. ) short interest as a percent of float has risen 6.44% since its last report. According to exchange reported data there are now Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.Short ...
Fri Feb 13, 2026
Piper Sandler See Label Expansion Potential for ImmunityBio Inc. (IBRX)s ANKTIVA Following QUILT Data. We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. ImmunityBio Inc. is among the best biotech stocks. TheFly reported on January 20 that Piper Sandler raised its price target on IBRX to $7 from $5 and maintained an Overweight rating. According to the update United States ANKTIVA net sales increased by almost 700% year [….]
Mon Feb 2, 2026
How Is The Market Feeling About ImmunityBio Inc?. ) short interest as a percent of float has risen 10.65% since its last report. According to exchange reported data there are now Short interest is the number of shares that have been sold short but have not yet been covered or closed out. is when a trader sells shares of a company they do not own with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.Short ...
Wed Jan 28, 2026
FIND US ON
Unlock the knowledge that 5,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
IBRX Stock trends
IBRX Stock performance
IBRX Stock analysis
IBRX investment strategies
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.